NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/12/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
35 |
| 05/15/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
62 |
| 11/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
224 |
| 08/13/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 05/14/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 11/13/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
97 |
| 08/10/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
95 |
| 05/22/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/16/23 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
2 | |
| 11/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |




